News + Resources
Life Sciences Mergers and Acquisitions (M&A): Myths vs. Facts
Mergers and acquisitions (M&A) allow life sciences companies of all sizes to bring together the resources, investment and expertise needed to develop and deliver new treatments and cures for patients. Decades of pro-innovation policies have helped catalyze this…
Pro-Innovation Mergers & Acquisitions: Maintaining America’s Leadership in Biopharmaceutical Breakthroughs
Thousands of U.S. life sciences companies race every day to find better treatments and cures for a wide range of conditions and diseases. Within this diverse and dynamic life sciences ecosystem – made up of early-stage companies, large-scale entities, research...
The Pro-Competition Policies Driving Life Science Innovation
America has a long history of enacting sound, bipartisan policies that have created powerful incentives for life sciences innovators to invest in the costly, extensive research and development (R&D) process behind groundbreaking treatments and cures. These...